• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对人低密度脂蛋白晚期糖基化终产物的自身免疫反应。

Autoimmune response to advanced glycosylation end-products of human LDL.

作者信息

Virella Gabriel, Thorpe Suzanne R, Alderson Nathan L, Stephan Elias M, Atchley Daniel, Wagner Francesco, Lopes-Virella Maria F

机构信息

Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC 92425, USA.

出版信息

J Lipid Res. 2003 Mar;44(3):487-93. doi: 10.1194/jlr.M200370-JLR200. Epub 2002 Dec 1.

DOI:10.1194/jlr.M200370-JLR200
PMID:12562876
Abstract

Advanced glycosylation end-products (AGEs) are believed to play a significant role in the development of vascular complications in diabetic patients. One such product, AGE-LDL, has been shown to be immunogenic. In this report, we describe the isolation and characterization of human AGE-LDL antibodies from the sera of seven patients with Type 1 diabetes by affinity chromatography using an immobilized AGE-LDL preparation that contained primarily the AGE N epsilon (carboxymethyl)lysine (CML, 14.6 mmol/mol lysine), and smaller amounts of N epsilon (carboxyethyl)lysine (CEL, 2.7 mmol/mol lysine). The isolated antibodies were predominantly IgG of subclasses 1 and 3, and considered proinflammatory because of their ability to promote Fc gamma R-mediated phagocytosis and to activate complement. We determined dissociation constants (Kd) for the purified antibodies. The average Kd values (4.76 +/- 2.52 x 10(-9) mol/l) indicated that AGE-LDL antibodies are of higher avidity than oxidized LDL antibodies measured previously (Kd = 1.53 +/- 07 x 10(-8) ml/l), but of lower avidity than rabbit polyclonal LDL antibodies (Kd = 9.34 x 10(-11)). Analysis of the apolipoprotein B-rich lipoproteins isolated with polyethylene glycol-precipitated antigen-antibody complexes from the same patients showed the presence of both CML and CEL, thus confirming that these two modifications are recognized by human autoantibodies. A comparative study of the reactivity of purified AGE-LDL antibodies with CML-LDL and CML-serum albumin showed no cross-reactivity.

摘要

晚期糖基化终末产物(AGEs)被认为在糖尿病患者血管并发症的发生发展中起重要作用。其中一种产物,AGE-LDL,已被证明具有免疫原性。在本报告中,我们描述了通过亲和色谱法从7名1型糖尿病患者的血清中分离和鉴定人AGE-LDL抗体的过程,该亲和色谱使用的固定化AGE-LDL制剂主要含有AGE Nε(羧甲基)赖氨酸(CML,14.6 mmol/mol赖氨酸)和少量的Nε(羧乙基)赖氨酸(CEL,2.7 mmol/mol赖氨酸)。分离出的抗体主要是1和3亚类的IgG,由于它们能够促进FcγR介导的吞噬作用并激活补体,因此被认为具有促炎作用。我们测定了纯化抗体的解离常数(Kd)。平均Kd值(4.76±2.52×10⁻⁹ mol/l)表明,AGE-LDL抗体的亲和力高于先前测定的氧化LDL抗体(Kd = 1.53±0.7×10⁻⁸ mol/l),但低于兔多克隆LDL抗体(Kd = 9.34×10⁻¹¹)。用聚乙二醇沉淀的抗原-抗体复合物从同一患者中分离出的富含载脂蛋白B的脂蛋白分析显示同时存在CML和CEL,从而证实这两种修饰可被人自身抗体识别。纯化的AGE-LDL抗体与CML-LDL和CML-血清白蛋白反应性的比较研究显示无交叉反应性。

相似文献

1
Autoimmune response to advanced glycosylation end-products of human LDL.对人低密度脂蛋白晚期糖基化终产物的自身免疫反应。
J Lipid Res. 2003 Mar;44(3):487-93. doi: 10.1194/jlr.M200370-JLR200. Epub 2002 Dec 1.
2
Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies.被人类自身抗体和兔超免疫抗体识别的修饰人低密度脂蛋白免疫原性形式的定义。
J Lipid Res. 2004 Oct;45(10):1859-67. doi: 10.1194/jlr.M400095-JLR200. Epub 2004 Jul 16.
3
Isolation and characterization of human antioxidized LDL autoantibodies.人抗氧化低密度脂蛋白自身抗体的分离与鉴定
Arterioscler Thromb Vasc Biol. 1996 Feb;16(2):222-9. doi: 10.1161/01.atv.16.2.222.
4
Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies.纯化的人氧化型低密度脂蛋白抗体的免疫化学特性分析
Clin Immunol. 2000 May;95(2):135-44. doi: 10.1006/clim.2000.4857.
5
The neoepitopes on methylglyoxal (MG) glycated LDL create autoimmune response; autoimmunity detection in T2DM patients with varying disease duration.甲基乙二醛(MG)糖化 LDL 上的新表位引发自身免疫反应;不同病程的 2 型糖尿病患者自身免疫检测。
Cell Immunol. 2020 May;351:104062. doi: 10.1016/j.cellimm.2020.104062. Epub 2020 Feb 7.
6
Antibodies against advanced glycation end product Nepsilon-(carboxymethyl)lysine in healthy controls and diabetic patients.健康对照者和糖尿病患者体内抗晚期糖基化终末产物Nε-(羧甲基)赖氨酸的抗体
Diabetologia. 2000 Nov;43(11):1385-8. doi: 10.1007/s001250051543.
7
In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.人体动脉粥样硬化斑块中低密度脂蛋白糖氧化的体内和体外证据。
Atherosclerosis. 2000 Jun;150(2):343-55. doi: 10.1016/s0021-9150(99)00396-2.
8
Development of capture assays for different modifications of human low-density lipoprotein.针对人低密度脂蛋白不同修饰的捕获检测方法的开发。
Clin Diagn Lab Immunol. 2005 Jan;12(1):68-75. doi: 10.1128/CDLI.12.1.68-75.2005.
9
The immunogenicity of modified lipoproteins.修饰脂蛋白的免疫原性。
Ann N Y Acad Sci. 2005 Jun;1043:367-78. doi: 10.1196/annals.1333.043.
10
Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions.晚期糖基化终末产物不同表位在人类动脉粥样硬化病变中的免疫组织化学定位
Atherosclerosis. 1998 Nov;141(1):61-75. doi: 10.1016/s0021-9150(98)00149-x.

引用本文的文献

1
Identification of Glycoxidative Lesion in Isolated Low-Density Lipoproteins from Diabetes Mellitus Subjects.糖尿病患者分离出的低密度脂蛋白中糖氧化损伤的鉴定。
Life (Basel). 2023 Sep 29;13(10):1986. doi: 10.3390/life13101986.
2
The Role of Advanced Glycation End Products on Dyslipidemia.晚期糖基化终末产物在血脂异常中的作用。
Metabolites. 2023 Jan 3;13(1):77. doi: 10.3390/metabo13010077.
3
Oxidised Low-Density Lipoprotein-Induced Platelet Hyperactivity-Receptors and Signalling Mechanisms.氧化型低密度脂蛋白诱导的血小板活性——受体和信号转导机制。
Int J Mol Sci. 2022 Aug 16;23(16):9199. doi: 10.3390/ijms23169199.
4
The 2022 Lady Estelle Wolfson lectureship on neurofilaments.2022 年埃斯特尔·沃尔夫森夫人神经丝讲座。
J Neurochem. 2022 Nov;163(3):179-219. doi: 10.1111/jnc.15682. Epub 2022 Sep 19.
5
Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis.修饰脂蛋白在动脉粥样硬化形成过程中诱导动脉壁炎症。
Front Cardiovasc Med. 2022 Mar 3;9:841545. doi: 10.3389/fcvm.2022.841545. eCollection 2022.
6
AGE/Non-AGE Glycation: An Important Event in Rheumatoid Arthritis Pathophysiology.AGE/非 AGE 糖基化:类风湿关节炎病理生理学中的一个重要事件。
Inflammation. 2022 Apr;45(2):477-496. doi: 10.1007/s10753-021-01589-7. Epub 2021 Nov 17.
7
Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes.针对甲基乙二醛修饰的载脂蛋白 B100 和载脂蛋白 B100 肽的自身抗体与长期 1 型糖尿病患者的冠状动脉粥样硬化和视网膜病变程度较轻相关。
Diabetes Care. 2021 Jun;44(6):1402-1409. doi: 10.2337/dc20-2089. Epub 2021 Apr 15.
8
Relationship between the risk factors of cardiovascular disease by testing biochemical markers and young men with erectile dysfunction: a case-control study.通过检测生化标志物探讨心血管疾病危险因素与年轻勃起功能障碍男性之间的关系:一项病例对照研究。
Transl Androl Urol. 2021 Feb;10(2):724-733. doi: 10.21037/tau-20-1056.
9
Pyridoxamine alleviates mechanical allodynia by suppressing the spinal receptor for advanced glycation end product-nuclear factor-B/extracellular signal-regulated kinase signaling pathway in diabetic rats.吡哆胺通过抑制糖尿病大鼠脊髓中晚期糖基化终产物受体-核因子-κB/细胞外信号调节激酶信号通路缓解机械性痛觉过敏。
Mol Pain. 2020 Jan-Dec;16:1744806920917251. doi: 10.1177/1744806920917251.
10
Structural Characterization and Physicochemical Stability Profile of a Double Mutant Heat Labile Toxin Protein Based Adjuvant.基于双重突变不耐热肠毒素蛋白的佐剂的结构特征和理化稳定性分析。
J Pharm Sci. 2017 Dec;106(12):3474-3485. doi: 10.1016/j.xphs.2017.07.019. Epub 2017 Aug 2.